Analytical Data
-
Gene name
dcyD
- Application
-
Alternative Names
dcyD; yedO; b1919; JW5313D-cysteine desulfhydrase; EC 4.4.1.15
-
Species
Escherichia coli
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P76316
-
Expression Region
2-328aa
-
Molecular Weight
39 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The dcyD gene encodes a protein that plays a crucial role in the absorption of dietary copper in various organisms, including humans. Copper is an essential trace element necessary for numerous physiological processes, including enzymatic reactions, iron metabolism, and the functioning of the nervous system. A deficiency or excess of copper can lead to several health issues, such as anemia, cardiovascular diseases, and neurological disorders. Research on the dcyD recombinant protein is focused on understanding its structure, function, and interaction with other proteins involved in copper transport mechanisms. By investigating the dcyD protein, scientists aim to uncover the molecular pathways that regulate copper homeostasis and identify potential therapeutic targets for conditions associated with copper imbalance. Moreover, the production of recombinant dcyD protein may facilitate the development of diagnostic tools and novel therapies to combat diseases arising from copper deficiency or overload, ultimately contributing to improved health outcomes. This research is particularly significant in the context of increasing awareness about the importance of trace minerals in human health and the rising prevalence of conditions related to nutrient imbalances.
